Dexamethasone Insert vs Loteprednol Etabonate Gel in Keratoconus Patients With Allergic Conjunctivitis

Phase 1, randomised, open-label trial of dexamethasone in allergic conjunctivitis (AC) and dry eye disease (DED) (2 arms), sponsored by Illinois College of Optometry. Primary endpoints: Effect of Dexamethasone Intracanalicular Insert on Patients With Keratoconus Who Also Have Allergies at 90 days, Effect of Dexamethasone Intracanalicular Insert on Patients With Keratoconus Who Also Have Elevated Osmolarity at 90 days and 2 more. Started Sep 2020; status: completed.